Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

5.700 -0.260 (-4.36%)
Official Closing Price Updated: 7:00 PM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
16 17 Next >
Target, Holley, Ferroglobe And Other Big Losers From Wednesday
U.S. stocks closed mostly lower on Wednesday, with the Nasdaq Composite dropping around 175 points. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
Why Ginkgo Bioworks Stock Is Sliding Wednesday Morning
Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading lower by 8.63% to $2.44 Wednesday morning. The company during Tuesday's after-hours session announced a public offering of Class A common... 
Via Benzinga
Carnival, Ginkgo Bioworks And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Ginkgo Bioworks Stock Is Down After Hours: What's Happening?
Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading lower in Tuesday's after-hours session after the company announced a proposed public offering. 
Via Benzinga
Co-founders Keep Buying Ginkgo Bioworks (DNA) Stock
Three co-founders of Ginkgo Bioworks, including CEO Jason Kelly, have filed updated forms detailing their increased stakes in DNA stock. 
Via InvestorPlace
What's Going On With Ginkgo Bioworks Stock After Hours?
Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading lower in Monday's after-hours session after the company  
Via Benzinga
3 Unstoppable Stocks That Could Double in 5 Years
The opportunities for these innovators are tremendous. 
Via The Motley Fool
Can Acquisitions and Partnerships Take Ginkgo Bioworks (DNA) Stock Higher?
It seems that Ginkgo Bioworks is announcing a new acquisition or collaboration every day this month, putting DNA stock in focus. 
Via InvestorPlace
Ignore the Hype! These Are 7 of the Worst Stocks to Own Now
Looking for great bear-market bargains? Separate the wheat from the chaff and avoid these seven stocks to sell. 
Via InvestorPlace
5 Top Stocks Cathie Wood Is Buying This Week
In an open letter to the Fed, Cathie Wood notes that deflationary fears could come to fruition, replacing inflationary fears. 
Via InvestorPlace
Morgan Stanley, First Republic Bank And Other Big Losers From Friday
U.S. stocks closed lower on Friday, with the Dow Jones dropping over 400 points. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
10 Top Stock Market Predictions for 2023
The top stock market predictions for 2023 show that the new year will be one in which hypergrowth stocks dominate. Don't miss out. 
Via InvestorPlace
DFLI Stock Alert: What to Know as Battery Maker Dragonfly Energy Starts Trading
Dragonfly Energy (DFLI) stock is catching the interest of traders on Tuesday after the company's shares went public yesterday. 
Via InvestorPlace
Merck Collaborates Ginkgo Bioworks to Improve Active Pharmaceutical Ingredient Manufacturing
Via Benzinga
What Is Going on With Vox Royalty (VOXR) Stock Today?
Vox Royalty (VOXR) stock is seeing incredibly volatile trading on Tuesday after the company uplisted shares to the Nasdaq Exchange. 
Via InvestorPlace
Why Is Laser Photonics (LASE) Stock Up 55% Today?
Laser Photonics (LASE) stock is taking off on Tuesday after the company revealed a new order from the U.S. Navy to be filled this month. 
Via InvestorPlace
What Is Going on With Ginkgo Bioworks (DNA) Stock Today?
Ginkgo's planned collab with a pharma giant should spark a rally in DNA stock - but then, sometimes logic doesn't prevail on Wall Street. 
Via InvestorPlace
5 Top Stocks Cathie Wood Is Buying This Week
Ark Invest is making headlines again. Cathie Wood continues to purchase more shares of companies like Tesla despite headwinds. 
Via InvestorPlace
2 Growth Stocks That Could Rocket 80% to 102% Higher, According to Wall Street
Analysts expect these stocks to rise more than 100% once the rest of the market sees their underlying businesses in the same light. 
Via The Motley Fool
Analyzing Ginkgo Bioworks Holdings's Short Interest
Ginkgo Bioworks Holdings's (NYSE:DNA) short percent of float has fallen 8.12% since its last report. The company recently reported that it has 187.61 million shares sold short, which is 25.02% of all... 
Via Benzinga
Cathie Wood Keeps Buying Ginkgo Bioworks (DNA) Stock
The famed investor who focuses on disruptive technologies has been buying DNA stock hand-over-fist in recent days. 
Via InvestorPlace
Why Is Ginkgo Bioworks Stock Up Today?
Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher Tuesday after the company announced the acquisitions of Altar and Circularis. Terms of the deals were not disclosed.  
Via Benzinga
5 Top Stocks Cathie Wood Is Buying This Week
There's a new Ark fund in town, and its name is the ARK Venture Fund. It will capitalize on democratizing private investments to the public. 
Via InvestorPlace
Netflix, Biogen And Other Big Gainers From Wednesday
U.S. stocks closed higher with the Dow Jones surging more than 500 points on Wednesday. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial... 
Via Benzinga
Cramer Warns Investor To Avoid This Entire Industry: 'I Do Not Want You To Touch Any Of These Stocks'
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended selling Everbridge Inc (NASDAQ: EVBG) as it does not make money. 
Via Benzinga
Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session
Gainers 
Via Benzinga
Peering Into Ginkgo Bioworks Holdings's Recent Short Interest
Ginkgo Bioworks Holdings's (NYSE:DNA) short percent of float has risen 24.11% since its last report. The company recently reported that it has 179.06 million shares sold short... 
Via Benzinga
5 Top Stocks Cathie Wood Is Buying This Week
Cathie Wood's Ark Invest had an active week of buying shares in companies like DKNG and TDOC. Investors are intrigued by Cathie Wood stocks. 
Via InvestorPlace
Don’t Jump Into the Deepening Financial Hole with Ginkgo Bioworks
You don't have to mimic Wood's trades, as DNA stock could continue its downward trajectory due to Ginkgo Bioworks' imperfect financials. 
Via InvestorPlace
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.